Fruit Smoothies | Blistex Inc. while Breastfeeding
It is a well known fact that breastfeeding is best source of nutrition for infants. Breast milk provides minerals, vitamins and antibodies in most acceptable format when they need it. Nutrition taken by mother passes to breast-milk and same thing applies to medicines taken by mothers. Not all drugs cause problem for baby but some do. Lets analyze if Fruit Smoothies | Blistex Inc. is safe for baby while breastfed.

What is Fruit Smoothies | Blistex Inc. used for?


temporarily protects and helps relieve chapped or cracked lips helps prevent sunburn

Purpose: Active ingredients Purpose Dimethicone 1.0% (w/w) Lip protectant Octinoxate 7.5% (w/w) Sunscreen Oxybenzone 2.5% (w/w) Sunscreen

I am breastfeeding mother and I am using Fruit Smoothies | Blistex Inc.. Can it have any bad effect on my kid? Shall I search for better alternative?

Fruit Smoothies | Blistex Inc. dangerous while breastfeeding
Our analysis of Dimethicone, Octinoxate, Oxybenzone, Dimethicone, Octinoxate, Oxybenzone, Dimethicone, Octinoxate, Oxybenzone, Dimethicone, Octinoxate, Oxybenzone which are active ingredients in Fruit Smoothies | Blistex Inc. indicates that Fruit Smoothies | Blistex Inc. is dangerous to use in breastfeeding. We strongly recommend you to go through detailed analysis of Dimethicone, Octinoxate, Oxybenzone, Dimethicone, Octinoxate, Oxybenzone, Dimethicone, Octinoxate, Oxybenzone, Dimethicone, Octinoxate, Oxybenzone as below and do not use Fruit Smoothies | Blistex Inc. during breastfeeding.

Fruit Smoothies | Blistex Inc. Breastfeeding Analsys


Dimethicone while Breastfeeding

Safe

CAS Number: 9006-65-9

Dimethicone is a fluid type of silicone with a methyl as organic group radical. Silicones are polymers of silicon tied to oxygen atoms with high molecular weight (see information on silicone and dimethicone). Dimethicone is water repellent and it is used in creams, dressings for skin protection and pediculicides. An activated form of Dimethicone is Simethicone that is used for treatment of flatulence (see info on Simethicone) At latest update, relevant published data on excretion into breast milk were not found. Because it is not absorbed through the skin or orally along with a high molecular weight, excretion into breast milk in significant amount or absorption by the infant gut is highly unlikely. See below the information of these related products:

Dimethicone while Breastfeeding

Safe

CAS Number: 9006-65-9

Dimethicone is a fluid type of silicone with a methyl as organic group radical. Silicones are polymers of silicon tied to oxygen atoms with high molecular weight (see information on silicone and dimethicone). Dimethicone is water repellent and it is used in creams, dressings for skin protection and pediculicides. An activated form of Dimethicone is Simethicone that is used for treatment of flatulence (see info on Simethicone) At latest update, relevant published data on excretion into breast milk were not found. Because it is not absorbed through the skin or orally along with a high molecular weight, excretion into breast milk in significant amount or absorption by the infant gut is highly unlikely. See below the information of these related products:

Dimethicone while Breastfeeding

Safe

CAS Number: 9006-65-9

Dimethicone is a fluid type of silicone with a methyl as organic group radical. Silicones are polymers of silicon tied to oxygen atoms with high molecular weight (see information on silicone and dimethicone). Dimethicone is water repellent and it is used in creams, dressings for skin protection and pediculicides. An activated form of Dimethicone is Simethicone that is used for treatment of flatulence (see info on Simethicone) At latest update, relevant published data on excretion into breast milk were not found. Because it is not absorbed through the skin or orally along with a high molecular weight, excretion into breast milk in significant amount or absorption by the infant gut is highly unlikely. See below the information of these related products:

Dimethicone while Breastfeeding

Safe

CAS Number: 9006-65-9

Dimethicone is a fluid type of silicone with a methyl as organic group radical. Silicones are polymers of silicon tied to oxygen atoms with high molecular weight (see information on silicone and dimethicone). Dimethicone is water repellent and it is used in creams, dressings for skin protection and pediculicides. An activated form of Dimethicone is Simethicone that is used for treatment of flatulence (see info on Simethicone) At latest update, relevant published data on excretion into breast milk were not found. Because it is not absorbed through the skin or orally along with a high molecular weight, excretion into breast milk in significant amount or absorption by the infant gut is highly unlikely. See below the information of these related products:


Fruit Smoothies | Blistex Inc. Breastfeeding Analsys - 2


Octinoxate and Breastfeeding

Unsafe

Octinoxate (Octylmethoxycinnamate) has been detected in human urine, blood and breast milk and is known for moderate risk of skin allergy. Some studies suggest that Octinoxate has estrogen like effects however less than 1% skin penetration has been found in human laboratory studies. As not much study has been done on effects of Octinoxate during breast feeding its recommended to use safe alternatives.

Octyl Methoxycinnamate (OMC) is a frequently used UV-filter in sunscreens and other cosmetics. Octinoxate can be systemically absorbed after skin application, being found in the deeper layers of the stratum corneum as well as urine, plasma, and breast milk. The mean maximum plasma concentration detected after application of 2mg/cm2 sunscreen was 7ng/mL in women and 16ng/mL in men. FDA study found blood levels 13 times above cutoff for systemic exposure.

Several studies indicated that OMC acts as an endocrine disruptor due to the ability to interfere with endocrine system at different levels. In humans OMC exposure has minor, but statistically significant effects on the levels of testosterone and estradiol. Moreover, some studies suggested that OMC can interact with the hypothalamo-pituitary-thyroid (HPT) axis.

Moreover, a study of offspring of dams treated with OMC (500–1000 mg/kg/day) showed sex-dependent behavioral changes, namely decreased motor activity in females, but not in males, and improved spatial learning in males, suggesting that OMC can affect neuronal development, however the doses used in these experiments were extremely high, not relevant to possible human exposure.

Note: Study and data for tropical use only

Warning: High dosage shall be avoided as reproductive system, thyroid and behavioral alterations in animal studies has been found, Tropical usage in breast area shall be avoided to prevent the OCTINOXATE passing orally in Infants.

Oxybenzone and Breastfeeding

Dangerous

Oxybenzone has been found in mother’s milk. And has relatively high 1% to 9% skin penetration in lab studies. Oxybenzone has relatively high rates of skin allergy, it has weak estrogen like effects, and its observed as moderate anti-androgen. Oxybenzone is associated with altered birth weight in human studies. It is not recommended to use Oxybenzone during breast feeding.

Note: Study and data for tropical use only.

Warning: Tropical usage in breast area shall be avoided to prevent the Oxybenzone passing orally in Infants.

Octinoxate and Breastfeeding

Unsafe

Octinoxate (Octylmethoxycinnamate) has been detected in human urine, blood and breast milk and is known for moderate risk of skin allergy. Some studies suggest that Octinoxate has estrogen like effects however less than 1% skin penetration has been found in human laboratory studies. As not much study has been done on effects of Octinoxate during breast feeding its recommended to use safe alternatives.

Octyl Methoxycinnamate (OMC) is a frequently used UV-filter in sunscreens and other cosmetics. Octinoxate can be systemically absorbed after skin application, being found in the deeper layers of the stratum corneum as well as urine, plasma, and breast milk. The mean maximum plasma concentration detected after application of 2mg/cm2 sunscreen was 7ng/mL in women and 16ng/mL in men. FDA study found blood levels 13 times above cutoff for systemic exposure.

Several studies indicated that OMC acts as an endocrine disruptor due to the ability to interfere with endocrine system at different levels. In humans OMC exposure has minor, but statistically significant effects on the levels of testosterone and estradiol. Moreover, some studies suggested that OMC can interact with the hypothalamo-pituitary-thyroid (HPT) axis.

Moreover, a study of offspring of dams treated with OMC (500–1000 mg/kg/day) showed sex-dependent behavioral changes, namely decreased motor activity in females, but not in males, and improved spatial learning in males, suggesting that OMC can affect neuronal development, however the doses used in these experiments were extremely high, not relevant to possible human exposure.

Note: Study and data for tropical use only

Warning: High dosage shall be avoided as reproductive system, thyroid and behavioral alterations in animal studies has been found, Tropical usage in breast area shall be avoided to prevent the OCTINOXATE passing orally in Infants.

Oxybenzone and Breastfeeding

Dangerous

Oxybenzone has been found in mother’s milk. And has relatively high 1% to 9% skin penetration in lab studies. Oxybenzone has relatively high rates of skin allergy, it has weak estrogen like effects, and its observed as moderate anti-androgen. Oxybenzone is associated with altered birth weight in human studies. It is not recommended to use Oxybenzone during breast feeding.

Note: Study and data for tropical use only.

Warning: Tropical usage in breast area shall be avoided to prevent the Oxybenzone passing orally in Infants.

Octinoxate and Breastfeeding

Unsafe

Octinoxate (Octylmethoxycinnamate) has been detected in human urine, blood and breast milk and is known for moderate risk of skin allergy. Some studies suggest that Octinoxate has estrogen like effects however less than 1% skin penetration has been found in human laboratory studies. As not much study has been done on effects of Octinoxate during breast feeding its recommended to use safe alternatives.

Octyl Methoxycinnamate (OMC) is a frequently used UV-filter in sunscreens and other cosmetics. Octinoxate can be systemically absorbed after skin application, being found in the deeper layers of the stratum corneum as well as urine, plasma, and breast milk. The mean maximum plasma concentration detected after application of 2mg/cm2 sunscreen was 7ng/mL in women and 16ng/mL in men. FDA study found blood levels 13 times above cutoff for systemic exposure.

Several studies indicated that OMC acts as an endocrine disruptor due to the ability to interfere with endocrine system at different levels. In humans OMC exposure has minor, but statistically significant effects on the levels of testosterone and estradiol. Moreover, some studies suggested that OMC can interact with the hypothalamo-pituitary-thyroid (HPT) axis.

Moreover, a study of offspring of dams treated with OMC (500–1000 mg/kg/day) showed sex-dependent behavioral changes, namely decreased motor activity in females, but not in males, and improved spatial learning in males, suggesting that OMC can affect neuronal development, however the doses used in these experiments were extremely high, not relevant to possible human exposure.

Note: Study and data for tropical use only

Warning: High dosage shall be avoided as reproductive system, thyroid and behavioral alterations in animal studies has been found, Tropical usage in breast area shall be avoided to prevent the OCTINOXATE passing orally in Infants.

Oxybenzone and Breastfeeding

Dangerous

Oxybenzone has been found in mother’s milk. And has relatively high 1% to 9% skin penetration in lab studies. Oxybenzone has relatively high rates of skin allergy, it has weak estrogen like effects, and its observed as moderate anti-androgen. Oxybenzone is associated with altered birth weight in human studies. It is not recommended to use Oxybenzone during breast feeding.

Note: Study and data for tropical use only.

Warning: Tropical usage in breast area shall be avoided to prevent the Oxybenzone passing orally in Infants.

Octinoxate and Breastfeeding

Unsafe

Octinoxate (Octylmethoxycinnamate) has been detected in human urine, blood and breast milk and is known for moderate risk of skin allergy. Some studies suggest that Octinoxate has estrogen like effects however less than 1% skin penetration has been found in human laboratory studies. As not much study has been done on effects of Octinoxate during breast feeding its recommended to use safe alternatives.

Octyl Methoxycinnamate (OMC) is a frequently used UV-filter in sunscreens and other cosmetics. Octinoxate can be systemically absorbed after skin application, being found in the deeper layers of the stratum corneum as well as urine, plasma, and breast milk. The mean maximum plasma concentration detected after application of 2mg/cm2 sunscreen was 7ng/mL in women and 16ng/mL in men. FDA study found blood levels 13 times above cutoff for systemic exposure.

Several studies indicated that OMC acts as an endocrine disruptor due to the ability to interfere with endocrine system at different levels. In humans OMC exposure has minor, but statistically significant effects on the levels of testosterone and estradiol. Moreover, some studies suggested that OMC can interact with the hypothalamo-pituitary-thyroid (HPT) axis.

Moreover, a study of offspring of dams treated with OMC (500–1000 mg/kg/day) showed sex-dependent behavioral changes, namely decreased motor activity in females, but not in males, and improved spatial learning in males, suggesting that OMC can affect neuronal development, however the doses used in these experiments were extremely high, not relevant to possible human exposure.

Note: Study and data for tropical use only

Warning: High dosage shall be avoided as reproductive system, thyroid and behavioral alterations in animal studies has been found, Tropical usage in breast area shall be avoided to prevent the OCTINOXATE passing orally in Infants.

Oxybenzone and Breastfeeding

Dangerous

Oxybenzone has been found in mother’s milk. And has relatively high 1% to 9% skin penetration in lab studies. Oxybenzone has relatively high rates of skin allergy, it has weak estrogen like effects, and its observed as moderate anti-androgen. Oxybenzone is associated with altered birth weight in human studies. It is not recommended to use Oxybenzone during breast feeding.

Note: Study and data for tropical use only.

Warning: Tropical usage in breast area shall be avoided to prevent the Oxybenzone passing orally in Infants.


What should I do if already breastfed my kid after using Fruit Smoothies | Blistex Inc.?

You should immediately inform your health care provider about Fruit Smoothies | Blistex Inc. usage and your breastfeeding interval after usage of . If you feel baby is having abnormal behavior or any other health issue please call 911 immediately or contact nearest medical emergency center.


I am nursing mother and my doctor has suggested me to use Fruit Smoothies | Blistex Inc., is it safe?

Please double check with your doctor if he is aware of your breastfeeding stratus, Ask your doctor if there is any safe alternative of Fruit Smoothies | Blistex Inc.. Check with your doctor if you shall temporally stop breastfeeding. You may go for second opinion as well. Still after all of this if your doctor still recommends Fruit Smoothies | Blistex Inc. then go for it as they have access on more detailed medical and scientific information and they understand your individual medical situation much better.


If I am using Fruit Smoothies | Blistex Inc., will my baby need extra monitoring?

Extreme level of monitoring required as Fruit Smoothies | Blistex Inc. could be dangerous for kid.


Who can I talk to if I have questions about usage of Fruit Smoothies | Blistex Inc. in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week